Ignite Creation Date:
2025-12-25 @ 2:15 AM
Ignite Modification Date:
2026-06-05 @ 7:56 PM
Study NCT ID:
NCT01253460
Status:
TERMINATED
Last Update Posted:
2019-09-06
First Post:
2010-12-01
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Sapacitabine, Cyclophosphamide, Rituximab for Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma (CLL/SLL) With Deletion (11q22-23)
Sponsor:
M.D. Anderson Cancer Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2010-0516
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None